Search projects

Try APPROACH

10 projects found

AB-Direct

Antibiotic distribution and recovery in tissue

Keywords IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials
Started
2019-07-01
f4571618-5f11-11eb-917b-acde48001122

AMR Accelerator

Antimicrobial Resistance Accelerator. Umbrella programme comprising the IMI projects AB-DIRECT, COMBINE, ERA4TB, GNA NOW, PRIMAVERA, RespiriNTM, RespiriTB, TRIC-TB and UNITE4TB

Keywords IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Clinical trial design Conducting clinical trials
effc9746-5f11-11eb-917b-acde48001122

COMBINE

Collaboration for prevention and treatment of MDR bacterial infections

Keywords IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Tools for predicting/monitoring efficacy Tools for predicting/monitoring safety +1 more
fairplus stamp
Started
2019-11-01
f435321e-5f11-11eb-917b-acde48001122

ERA4TB

European regimen accelerator for tuberculosis

Keywords IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator
Started
2020-01-01
f17922f6-5f11-11eb-917b-acde48001122

GNA NOW

Novel Gram-negative antibiotic now

Keywords IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials
fairplus stamp
Started
2019-07-01
f48896de-5f11-11eb-917b-acde48001122

PRIMAVERA

Predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance

Keywords IMI projects Antimicrobial resistance Infectious diseases Vaccines Biologicals AMR Accelerator +1 more
Started
2021-11-01
c905e85a-c98a-11ed-a11d-ea435b63c148

RespiriNTM

Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs

Keywords IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials Target identification
Started
2019-05-01
f4e40262-5f11-11eb-917b-acde48001122

RespiriTB

Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

Keywords IMI projects Antimicrobial resistance Infectious diseases AMR Accelerator Conducting clinical trials
Started
2019-05-01
f32fb9f2-5f11-11eb-917b-acde48001122